How to Build a Business Development Team at a CRO or CDMO: The First 90 Days
A small CRO or CDMO builds a business development function in 90 days by installing a system before hiring people: a written ideal customer profile, a named target list, one problem-led outbound sequence, a minimum viable CRM and three numbers reviewed every week. Corstrate helps 20 to 150 person service providers build that system and run it until it pays for a hire.
Author: Imen Jelassi, Founder, Corstrate, Life Sciences Business Development Consultant
Key Takeaways
Referrals stop scaling, usually without warning. Mid-tier CROs have cut billable rates by 10% to 15% to win work, and large sponsors are delaying non-essential projects by four to six months (IntuitionLabs, citing Third Bridge, 2026). A pipeline that depends on who already knows you cannot absorb that.
System first, people second. The most expensive false start is hiring a salesperson before there is an ICP, a list and a message for them to work with.
Buyers decide before they talk to you. 67% of B2B buyers now prefer a rep-free experience and 45% used AI during a recent purchase (Gartner, 2026). Your outreach has to be useful enough to earn a conversation.
Ninety days is enough to know. By day 90 you should have a tested sequence, a clean pipeline and real conversion numbers, which is what you need to decide who owns BD long term.
Measure three things weekly. First meetings booked, qualified opportunities created and pipeline value against target. Everything else is detail.
Why referral-led growth stalls at small CROs and CDMOs
Most small service providers grow the same way. A founder or a scientific lead has a strong network, early clients refer the next ones, and for years there is no need for anything that looks like a sales function. Then three things happen together: the original contacts move company or retire, a large client is acquired or cuts its vendor list, and the team grows faster than the network.
The market makes this worse in 2026. Mid-tier CROs are reported to have cut billable labor rates by 10% to 15% to win work, while large sponsors push for lower prices and delay projects by four to six months (IntuitionLabs, citing Third Bridge, 2026). Sponsors are also consolidating suppliers, which we covered in our guide to getting on a pharma preferred vendor list. When the pipeline depends on a handful of relationships, any one of these events creates a revenue gap six months later.
This guide is the practical answer to how to build a business development team CRO CDMO leaders can rely on, starting from zero and without a large budget. It sits between two earlier pieces: fractional BD vs hiring in-house, which covers the who, and how life sciences vendors win more pharma and biotech clients, which covers the what. This one covers the how.
The three false starts to avoid
1. Hiring a rep with no system
A new BD manager arrives, asks who the target clients are, and gets a vague answer: "biotech and pharma, anyone running trials." They spend three months building a list, writing messages and choosing tools. By the time they start selling, leadership is already asking where the pipeline is. A mid-market account executive costs roughly $203,000 to $214,000 a year fully loaded and takes about five months to ramp even with a system in place (Stealth Agents, 2026). Without one, the ramp is longer and the failure rate higher.
2. Buying a database first
Contact data is a means, not a plan. Companies that buy a large database before defining their ICP end up emailing thousands of loosely relevant people, damage their sending domain and conclude that "outbound does not work in life sciences." It does work, on a small, well-chosen list.
3. Leading with capabilities instead of problems
"We are a full-service CRO with 20 years of experience in oncology, cardiology, CNS and rare diseases" is the most common opening line in our industry, and the least effective. Sponsors respond to a specific problem they recognize: a delayed first patient in, a tech transfer that slipped, a vendor that did not answer in their time zone. Lead with the problem, then show proof that you solve it.
How to build a business development team at a CRO or CDMO in 90 days
Days 1 to 30: foundations
Weeks 1 and 2, define the ICP from your own data. List your best ten clients from the last three years. For each, note company type and size, development stage, therapeutic area or modality, who signed, how they found you and why they stayed. Your ICP is the pattern, written on one page, including who you do not want.
Week 2, write the problem statements. Three to five problems your best clients had before they hired you, in their words. These become your messaging.
Week 3, build the named target list. 150 to 300 accounts that match the ICP, with two or three named contacts each: the functional buyer (clinical operations, CMC, quality), the budget owner and, where relevant, procurement. Use trigger events such as a recent financing or a phase transition to rank them. Our pharmaceutical lead generation guide covers sourcing.
Week 4, set up a minimum viable CRM. One pipeline, five or six stages with clear exit criteria, and one owner per record. A spreadsheet is acceptable for the first month. A tool is only useful once the stages are agreed.
Days 31 to 60: the first outbound motion
Launch one sequence, not five. Four to five emails over three to four weeks, each tied to one problem statement, plus a LinkedIn connection and two light touches. See our LinkedIn prospecting guide for the social side.
Benchmark honestly. Cold email reply rates average roughly 5% to 9% across industries, and well-targeted segments can reach 15% or more; the first follow-up typically adds a large share of total replies (Instantly, 2026). If you are far below 5%, the list or the message is wrong, not the channel.
Use one event. Pick the conference where your ICP actually goes and pre-book meetings with target accounts. Our guide to conference meeting generation explains how.
Hold a weekly 30-minute pipeline review. Same day, same three numbers, decisions recorded.
Days 61 to 90: measure, refine and decide
Rewrite what is not working. Replace the weakest email, drop the segment that does not reply, double the one that does.
Calculate coverage. Compare pipeline value with the revenue target for the next 12 months. Our article on a predictable sales pipeline for a small CRO includes the worked coverage example.
Decide who owns BD next. With real conversion data, you can now decide whether to keep a founder-led model, hire, or continue with external support.
Minimum viable CRM: the stages that matter
Stage | Exit criterion | Owner action |
Target | Account matches the written ICP | Add two or three named contacts |
Engaged | Contact replied or accepted a meeting | Book a first call within five working days |
Qualified | Real project, timing and budget owner confirmed | Agree next step with a date |
Proposal | RFP received or proposal sent | Follow the RFP response process |
Negotiation | Sponsor confirmed preferred vendor status | Agree contract and MSA path |
Won / Lost | Signed, or reason for loss recorded | Log the reason in one line |
Keep it this simple for the first 90 days. More stages create more debate and less selling. The pipeline optimization guide goes further once the basics are stable.
What to measure at day 30, 60 and 90
Checkpoint | What should exist | Numbers to review |
Day 30 | One-page ICP, problem statements, 150 to 300 named accounts, CRM stages agreed | Accounts and contacts loaded, data completeness |
Day 60 | One live sequence, one event plan, weekly review running | Reply rate, first meetings booked, meetings held |
Day 90 | Refined sequence, first qualified opportunities, coverage calculation | Qualified opportunities, pipeline value vs target, meeting to opportunity conversion |
Do not judge the function on revenue at day 90. In life sciences services, sales cycles are long. Judge it on whether qualified pipeline is being created at a predictable rate.
Who should run it: four options compared
Criterion | Founder-led with a system | Junior BD rep | Senior BD hire | Fractional BD partner |
Year-one cost | Founder time | Salary and tools, plus management time | About $200,000+ fully loaded | Corstrate estimate: roughly $60,000 to $150,000 |
Time to first meetings | 4 to 8 weeks | 3 to 4 months including hiring | 5 to 8 months including hiring and ramp | 2 to 4 weeks |
Builds the system? | Only if time allows | No, needs one | Yes, slowly | Yes, core of the role |
Risk if it fails | Delivery suffers | Rep leaves, list and know-how lost | High cost, lost year | Low, short notice period |
Best fit | Under 30 people, strong founder network | Once ICP and sequence are proven | Pipeline proven, need to scale | Building from zero, or between hires |
Many small CROs and CDMOs combine two: a fractional partner builds and runs the system for the first six months, then hands it to a junior rep or a senior hire. Our fractional business development guide explains how that hand-over works.
When Corstrate is the right fit, and when it is not
Corstrate is a boutique business development consultancy for CROs, CDMOs, biotech and pharma service providers in the US and EU. We are a good fit when you need the BD function built and running quickly: ICP, target lists, sequences, conference meetings and weekly pipeline reporting.
We are not the right choice if you need a recruiter to hire a permanent sales team, a CRM implementation partner for a complex enterprise system, or a marketing agency for brand and website work. Bring us in for the pipeline, and use specialists for the rest.
Frequently asked questions
How do you build a business development team at a small CRO or CDMO? Build the system before hiring people: write a one-page ideal customer profile, build a named list of 150 to 300 target accounts, launch one problem-led outbound sequence, set up a simple CRM with clear stages, and review three numbers every week. After 90 days, use the results to decide who owns BD.
Should a small CRO hire a BD manager or use a fractional BD consultant first? If there is no ICP, target list or proven message yet, a fractional BD partner is usually lower risk, because it builds the system and starts generating meetings within weeks. Hire once the motion is proven and there is enough pipeline to keep a full-time person productive.
What should a CDMO measure in the first 90 days of business development? At day 30, the ICP, target list and CRM stages. At day 60, reply rate and first meetings booked. At day 90, qualified opportunities, pipeline value against target and meeting to opportunity conversion. Revenue comes later because sales cycles are long.
What are the most common mistakes when building a BD function from scratch? Hiring a rep with no system to work with, buying a large contact database before defining the ICP, and leading outreach with a list of capabilities instead of a specific problem the sponsor recognizes.
What reply rate should a CRO expect from cold email outreach? Across industries, cold email reply rates average roughly 5% to 9%, and tightly targeted segments can reach 15% or more. If a life sciences sequence is well below 5%, fix the list or the message before changing channel.
Sources
IntuitionLabs, CRO market share 2026 (citing Third Bridge on mid-tier CRO pricing): https://intuitionlabs.ai/articles/cro-market-share-2026
Gartner, sales survey on rep-free buying, March 2026: https://www.gartner.com/en/newsroom/press-releases/2026-03-09-gartner-sales-survey-finds-67-percent-of-b2b-buyers-prefer-a-rep-free-experience
Stealth Agents, cost of hiring a sales representative 2026: https://stealthagents.com/research/cost-of-hiring-a-sales-representative-2026
Instantly, cold email reply rate benchmarks 2026: https://instantly.ai/blog/cold-email-reply-rate-benchmarks?lng=en
Comments